Opportunity ID: 228549

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-13-166
Funding Opportunity Title: Innovative Research Methods: Prevention and Management of Symptoms in Chronic Illness (R15)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.361 — Nursing Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 29, 2013
Last Updated Date:
Original Closing Date for Applications: May 07, 2016
Current Closing Date for Applications: May 07, 2016
Archive Date: Jun 07, 2016
Estimated Total Program Funding:
Award Ceiling: $300,000
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity seeks to update the randomized control trial (RCT) design using novel research methods that are practical, innovative, and hold promise for producing more effective outcomes. Novel clinical research designs, applied to symptom management trials, may identify those treatment strategies that best alter the course of symptom burden in chronic illness by addressing the issues of varied treatment responses across patients, subject retention, and adherence to treatment regimens. For example, sequential multiple assignment randomization trials (SMART) design have been used successfully to develop dynamic treatment regimens for alcohol, depression and HIV infection but are not widely used in symptom management trials. The approach is pragmatic in that it mimics clinical practice by allowing a re-evaluation of treatment options based on an individuals progress towards treatment goals. The levels or inclusion of intervention components are tailored in response to individual characteristics or progress toward a treatment goal. Subjects may be randomly assigned several times to varying amounts and types of intervention components based on predetermined decision rules. This sequential decision making process allows for the initial intervention to be adapted and provides subjects with options for achieving a favorable outcome. A Multiphase optimization strategy (MOST) could also prove useful when applied to symptom management trials.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-13-166.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
ADOBE-FORMS-B2 Adobe-Forms-B2 PKG00171755 May 25, 2013 Sep 24, 2013 View
FORMS-C Use for due dates after 9/24/2013 PKG00181475 Sep 25, 2013 May 07, 2016 View

Package 1

Mandatory forms

228549 RR_SF424_1_2-1.2.pdf

228549 PerformanceSite_1_4-1.4.pdf

228549 RR_OtherProjectInfo_1_3-1.3.pdf

228549 RR_KeyPersonExpanded_1_2-1.2.pdf

228549 PHS398_CoverPageSupplement_1_4-1.4.pdf

228549 PHS398_ResearchPlan_1_3-1.3.pdf

228549 PHS398_Checklist_1_3-1.3.pdf

Optional forms

228549 RR_SubawardBudget30-1.2.pdf

228549 PHS398_ModularBudget_1_2-1.2.pdf

228549 RR_Budget-1.1.pdf

228549 PHS_CoverLetter_1_2-1.2.pdf

Package 2

Mandatory forms

228549 RR_SF424_2_0-2.0.pdf

228549 PHS398_ResearchPlan_2_0-2.0.pdf

228549 PHS398_CoverPageSupplement_2_0-2.0.pdf

228549 RR_KeyPersonExpanded_2_0-2.0.pdf

228549 RR_OtherProjectInfo_1_3-1.3.pdf

228549 PerformanceSite_2_0-2.0.pdf

Optional forms

228549 RR_SubawardBudget30_1_3-1.3.pdf

228549 PlannedReport-1.0.pdf

228549 PHS398_CumulativeInclusionReport-1.0.pdf

228549 PHS398_ModularBudget_1_2-1.2.pdf

228549 RR_Budget_1_3-1.3.pdf

2025-07-11T15:39:31-05:00

Share This Post, Choose Your Platform!

About the Author: